Cochrane Abstracts
Site‐specific chemotherapy based on gene expression profiling versus empirical chemotherapy for people with cancer of unknown primary site
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Site‐specific Chemotherapy Based On Gene Expression Profiling Versus Empirical Chemotherapy for People With Cancer of Unknown Primary Site." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431989/all/Site‐specific_chemotherapy_based_on_gene_expression_profiling_versus_empirical_chemotherapy_for_people_with_cancer_of_unknown_primary_site.
Site‐specific chemotherapy based on gene expression profiling versus empirical chemotherapy for people with cancer of unknown primary site. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431989/all/Site‐specific_chemotherapy_based_on_gene_expression_profiling_versus_empirical_chemotherapy_for_people_with_cancer_of_unknown_primary_site. Accessed July 19, 2025.
Site‐specific chemotherapy based on gene expression profiling versus empirical chemotherapy for people with cancer of unknown primary site. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431989/all/Site‐specific_chemotherapy_based_on_gene_expression_profiling_versus_empirical_chemotherapy_for_people_with_cancer_of_unknown_primary_site
Site‐specific Chemotherapy Based On Gene Expression Profiling Versus Empirical Chemotherapy for People With Cancer of Unknown Primary Site [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 July 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431989/all/Site‐specific_chemotherapy_based_on_gene_expression_profiling_versus_empirical_chemotherapy_for_people_with_cancer_of_unknown_primary_site.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Site‐specific chemotherapy based on gene expression profiling versus empirical chemotherapy for people with cancer of unknown primary site
ID - 431989
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431989/all/Site‐specific_chemotherapy_based_on_gene_expression_profiling_versus_empirical_chemotherapy_for_people_with_cancer_of_unknown_primary_site
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
